(Q73933683)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9394783%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

title

Treatment with intact anti-B7-1 mAb during disease remission enhances epitope spreading and exacerbates relapses in R-EAE (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9394783%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9394783%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

author name string

C L Vanderlugt

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9394783%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

D J Lenschow

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9394783%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

M C Dal Canto

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9394783%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

J A Bluestone

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9394783%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

S D Miller

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9394783%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

publication date

1 November 1997

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9394783%20AND%20SRC:MED&resulttype=core&format=json

Journal of Neuroimmunology

7 November 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9394783%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

volume

79

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9394783%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

issue

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9394783%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

page(s)

113-118

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9394783%20AND%20SRC:MED&resulttype=core&format=json

Treatment of murine lupus with CTLA4Ig

7 November 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2897%2900108-2

7 January 2021

Genetic and molecular aspects of demyelination

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2897%2900108-2

7 January 2021

Antigen presentation by chemically modified splenocytes induces antigen-specific T cell unresponsiveness in vitro and in vivo

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2897%2900108-2

7 January 2021

CTLA-4: a negative regulator of autoimmune disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2897%2900108-2

7 January 2021

Monoclonal antibody-induced inhibition of relapsing EAE in SJL/J mice correlates with inhibition of neuroantigen-specific cell-mediated immune responses

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2897%2900108-2

7 January 2021

B7-1 and B7-2 costimulatory molecules activate differentially the Th1/Th2 developmental pathways: application to autoimmune disease therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2897%2900108-2

7 January 2021

Long-term survival of xenogeneic pancreatic islet grafts induced by CTLA4lg

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2897%2900108-2

7 January 2021

Expression and functional significance of an additional ligand for CTLA-4.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2897%2900108-2

7 January 2021

Differential effects of anti-B7-1 and anti-B7-2 monoclonal antibody treatment on the development of diabetes in the nonobese diabetic mouse

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2897%2900108-2

7 January 2021

Inhibition of transplant rejection following treatment with anti-B7-2 and anti-B7-1 antibodies

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2897%2900108-2

7 January 2021

Immunosuppression in vivo by a soluble form of the CTLA-4 T cell activation molecule

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2897%2900108-2

7 January 2021

Induction of active and adoptive relapsing experimental autoimmune encephalomyelitis (EAE) using an encephalitogenic epitope of proteolipid protein

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2897%2900108-2

7 January 2021

Functional evidence for epitope spreading in the relapsing pathology of experimental autoimmune encephalomyelitis

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2897%2900108-2

7 January 2021

The immunopathogenesis and regulation of T-cell-mediated demyelinating diseases

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2897%2900108-2

7 January 2021

Evolution of the T‐Cell Repertoire during the Course of Experimental Immune‐Mediated Demyelinating Diseases

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2897%2900108-2

7 January 2021

Blockade of CD28/B7-1 interaction prevents epitope spreading and clinical relapses of murine EAE

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2897%2900108-2

7 January 2021

Clonal expansion versus functional clonal inactivation: a costimulatory signalling pathway determines the outcome of T cell antigen receptor occupancy

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2897%2900108-2

7 January 2021

Signalling through the MHC class II cytoplasmic domain is required for antigen presentation and induces B7 expression

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2897%2900108-2

7 January 2021

Distinct roles for B7-1 (CD-80) and B7-2 (CD-86) in the initiation of experimental allergic encephalomyelitis

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2897%2900108-2

7 January 2021

CTLA-4 can function as a negative regulator of T cell activation

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2897%2900108-2

7 January 2021

10.1016/S0165-5728(97)00108-2

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9394783%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

1 reference